Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
portion decrease » proportional decrease (Expand Search)
point decrease » point increase (Expand Search)
Showing 1,521 - 1,540 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((portion decrease) OR (point decrease)) ))', query time: 0.50s Refine Results
  1. 1521
    Correlation between relative amounts of lipid species and number of days since the onset of symptoms among COVID-19 cases.

    Correlation between relative amounts of lipid species and number of days since the onset of symptoms among COVID-19 cases. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1522
    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (<i>TF, Serotransferrin; F2, Prothrombin; CFI, Complement factor I; HPX, Hemopexin; C4A/C4B, Complement C4b; GC, Vitamin D-binding protein; SERPINA7, Thyroxine-binding globulin; CFB, Complement factor B; APOH, Beta-2-glycoprotein 1; NTM, Neurotrimin</i>).

    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1523
    General characteristics and clinical data of the subjects included in the study.

    General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1524
    Distribution of average relative amounts of lipid classes.

    Distribution of average relative amounts of lipid classes. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1525
    Flow chart on the inclusion and drop out of patients.

    Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1526
    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls.

    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1527
    Symptoms reported by COVID-19 cases at baseline and at follow-up.

    Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1528
    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means.

    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

    Published 2025
    Save to List
    Saved in:
  9. 1529
    Effects of BM-MSCs on ROS generation in DCS rats.

    Effects of BM-MSCs on ROS generation in DCS rats. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1530
    Pretreatment of BM-MSCs attenuates DCS induced lung inflammation.

    Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1531
    Isotype control overlays.

    Isotype control overlays. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1532
    Original uncropped blot.

    Original uncropped blot. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1533
    Characterization of BM-MSC.

    Characterization of BM-MSC. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1534
    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS.

    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1535
    Utilization of anticoagulants at eight hospitals from 2019 to 2023.

    Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1536
    Identification of BM-MSCs.

    Identification of BM-MSCs. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1537
    Effect of BM-MSCs in improving DCS induced lung injury.

    Effect of BM-MSCs in improving DCS induced lung injury. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1538
    Inpatient utilization of anticoagulants from 2019 to 2023.

    Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1539
    Indications for warfarin prescription in outpatients and inpatients in 2023.

    Indications for warfarin prescription in outpatients and inpatients in 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1540
    Western blotting for OMP expression using olfactory bulb and olfactory epithelium.

    Western blotting for OMP expression using olfactory bulb and olfactory epithelium. by Myeongguk Jeong (16386165)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: